Observational studyArthritis research & therapy2013

The immunogenicity to the first anti-TNF therapy determines the outcome of switching to a second anti-TNF therapy in spondyloarthritis patients.

Chamaida Plasencia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.